{"date":"2025-08-29","count":30,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6734-2025-08-29-2008-114drjt","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2025-08-29","time":"20:08:17","subject":"公告本公司114年7月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"第44款","fact_date":"2025-08-29","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2025-08-29 20:08，「公告本公司114年7月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-08-29-1944-dhqwd1","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-08-29","time":"19:44:49","subject":"本公司民國114年度第二季合併財務報告業經董事會決議通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-08-29 19:44，「本公司民國114年度第二季合併財務報告業經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-08-29-1944-o0aovs","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-08-29","time":"19:44:31","subject":"公告本公司背書保證達「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項第四款之公告標準","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-08-29 19:44，「公告本公司背書保證達「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項第四款之公告標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-08-29-1944-gt8qfq","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-08-29","time":"19:44:05","subject":"公告本公司113年現金增資發行新股之資金運用計畫變更","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-08-29 19:44，「公告本公司113年現金增資發行新股之資金運用計畫變更」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-08-29-1943-1g59lrp","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-08-29","time":"19:43:42","subject":"本公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第一款之規定辦理公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-08-29 19:43，「本公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第一款之規定辦理公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-08-29-1943-qeifnh","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-08-29","time":"19:43:23","subject":"公告本公司董事會通過現金增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-08-29 19:43，「公告本公司董事會通過現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-08-29-1940-l7qirp","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-08-29","time":"19:40:33","subject":"公告本公司會計主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-08-29 19:40，「公告本公司會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2025-08-29-1857-ec23cx","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2025-08-29","time":"18:57:31","subject":"更正114年4-6月份關係人交易申報數","clause":"第51款","fact_date":"2025-08-29","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2025-08-29 18:57，「更正114年4-6月份關係人交易申報數」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6885-2025-08-29-1851-1oudm8","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2025-08-29","time":"18:51:39","subject":"公告本公司解除經理人競業禁止之限制案","clause":"第21款","fact_date":"2025-08-29","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2025-08-29 18:51，「公告本公司解除經理人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7860-2025-08-29-1732-1jwoim9","company_id":"7860","company":"得生製藥","market":"興櫃","industry":"生技醫療","date":"2025-08-29","time":"17:32:42","subject":"本公司受邀參加福邦證券舉辦之興櫃前法人說明會。","clause":"第9款","fact_date":"2025-09-03","cite_as":"公開資訊觀測站重大訊息：得生製藥（7860），2025-08-29 17:32，「本公司受邀參加福邦證券舉辦之興櫃前法人說明會。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-08-29-1727-1otid7","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-08-29","time":"17:27:44","subject":"公告本公司「經修飾的巨噬細胞、其組成物及其用途」取得加拿大發明專利","clause":"第44款","fact_date":"2025-08-29","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-08-29 17:27，「公告本公司「經修飾的巨噬細胞、其組成物及其用途」取得加拿大發明專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-08-29-1721-1u9587f","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-08-29","time":"17:21:32","subject":"公告本公司開發之周邊血液單核細胞純化技術授權株式會社A&i向日本安全未來特定認定再生醫療等委員會申請審查通過並取得日本厚生勞動省的再生醫學治療計劃","clause":"第44款","fact_date":"2025-08-29","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-08-29 17:21，「公告本公司開發之周邊血液單核細胞純化技術授權株式會社A&i向日本安全未來特定認定再生醫療等委員會申請審查通過並取得日本厚」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2025-08-29-1629-eamvb0","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2025-08-29","time":"16:29:38","subject":"衛福部核准本公司與國軍桃園總醫院附設民眾診療服務處合作之自體脂肪幹細胞治療退化性關節炎及膝關節軟骨缺損計畫","clause":"第53款","fact_date":"2025-08-29","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2025-08-29 16:29，「衛福部核准本公司與國軍桃園總醫院附設民眾診療服務處合作之自體脂肪幹細胞治療退化性關節炎及膝關節軟骨缺損計畫」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2025-08-29-1619-5jlbip","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2025-08-29","time":"16:19:23","subject":"公告本公司114年7月份自結合併財務報告之負債比率、流動比率及速動比率","clause":"第44款","fact_date":"2025-08-29","cite_as":"公開資訊觀測站重大訊息：普生（4117），2025-08-29 16:19，「公告本公司114年7月份自結合併財務報告之負債比率、流動比率及速動比率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-08-29-1618-rx97no","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-08-29","time":"16:18:32","subject":"本公司研發之 F18 FBPA 注射劑向台灣衛生福利部食品藥物管理署(TFDA)提出學術研究用人體臨床試驗審查申請(IND)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-08-29 16:18，「本公司研發之 F18 FBPA 注射劑向台灣衛生福利部食品藥物管理署(TFDA)提出學術研究用人體臨床試驗審查申請(IN」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-08-29-1609-1pzjlpi","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-08-29","time":"16:09:04","subject":"公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"第44款","fact_date":"2025-08-29","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-08-29 16:09，「公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2025-08-29-1604-bjjake","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-29","time":"16:04:00","subject":"本公司訂定114年現金增資認股基準日暨相關事宜(補充代收款項及存儲款項機構等相關事宜)(更正事實發生日及內容1.)","clause":"第9款","fact_date":"2025-08-29","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2025-08-29 16:04，「本公司訂定114年現金增資認股基準日暨相關事宜(補充代收款項及存儲款項機構等相關事宜)(更正事實發生日及內容1.)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2025-08-29-1552-peusgi","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2025-08-29","time":"15:52:21","subject":"公告本公司第四屆審計委員會委員","clause":"第6款","fact_date":"2025-08-29","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2025-08-29 15:52，「公告本公司第四屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2025-08-29-1551-wv5t1q","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2025-08-29","time":"15:51:32","subject":"公告本公司董事會決議委任薪資報酬委員","clause":"第6款","fact_date":"2025-08-29","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2025-08-29 15:51，「公告本公司董事會決議委任薪資報酬委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2025-08-29-1545-1m17pam","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2025-08-29","time":"15:45:26","subject":"公告本公司董事會選任董事長及副董事長","clause":"第6款","fact_date":"2025-08-29","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2025-08-29 15:45，「公告本公司董事會選任董事長及副董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2025-08-29-1544-1hxowcr","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2025-08-29","time":"15:44:48","subject":"公告本公司114年第一次股東臨時會通過解除新任董事及其代表人競業禁止之限制","clause":"第21款","fact_date":"2025-08-29","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2025-08-29 15:44，「公告本公司114年第一次股東臨時會通過解除新任董事及其代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2025-08-29-1544-171082y","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2025-08-29","time":"15:44:07","subject":"公告本公司114年第一次股東臨時會會全面改選董事(含獨立董事)","clause":"第6款","fact_date":"2025-08-29","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2025-08-29 15:44，「公告本公司114年第一次股東臨時會會全面改選董事(含獨立董事)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2025-08-29-1543-ub84r7","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2025-08-29","time":"15:43:10","subject":"公告本公司114年第一次股東臨時會重要決議事項","clause":"第18款","fact_date":"2025-08-29","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2025-08-29 15:43，「公告本公司114年第一次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2025-08-29-1534-1fwt5mi","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-29","time":"15:34:39","subject":"本公司訂定114年現金增資認股基準日暨相關事宜(補充代收款項及存儲款項機構等相關事宜)","clause":"第9款","fact_date":"2025-08-27","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2025-08-29 15:34，「本公司訂定114年現金增資認股基準日暨相關事宜(補充代收款項及存儲款項機構等相關事宜)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-08-29-1532-1gmdoxx","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-08-29","time":"15:32:51","subject":"公告本公司到手香萃取物取得美國「製備到手香萃取物的方法」發明專利","clause":"第53款","fact_date":"2025-08-29","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-08-29 15:32，「公告本公司到手香萃取物取得美國「製備到手香萃取物的方法」發明專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2025-08-29-1519-x9jh0l","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2025-08-29","time":"15:19:53","subject":"本公司法人董事之代表人變動公告","clause":"第6款","fact_date":"2025-08-29","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2025-08-29 15:19，「本公司法人董事之代表人變動公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2025-08-29-1508-1nbjc38","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2025-08-29","time":"15:08:52","subject":"公告本公司庫藏股買回數量達已發行股份總數百分之二","clause":"第35款","fact_date":"2025-08-29","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2025-08-29 15:08，「公告本公司庫藏股買回數量達已發行股份總數百分之二」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2025-08-29-1508-1k2ge8v","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2025-08-29","time":"15:08:02","subject":"代子公司「中國化學製藥股份有限公司」公告主辦會計異動","clause":"第8款","fact_date":"2025-08-29","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2025-08-29 15:08，「代子公司「中國化學製藥股份有限公司」公告主辦會計異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2025-08-29-1505-13aviur","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2025-08-29","time":"15:05:43","subject":"向關係⼈處分使⽤權資產提前終⽌租約案(補充說明)","clause":"第20款","fact_date":"2025-08-29","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2025-08-29 15:05，「向關係⼈處分使⽤權資產提前終⽌租約案(補充說明)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4108-2025-08-29-1443-p67uuk","company_id":"4108","company":"懷特","market":"上市","industry":"生技醫療","date":"2025-08-29","time":"14:43:55","subject":"公告本公司內部稽核主管異動","clause":"第8款","fact_date":"2025-08-31","cite_as":"公開資訊觀測站重大訊息：懷特（4108），2025-08-29 14:43，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}